Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

918
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
918
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

3.7K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
3.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

783
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
783

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mendelian Randomization in Eye Research: Powerful, but Prone to Misuse.

Translational vision science & technology·2025
Same author

A Catalog of Patent Applications Published in 2024 Related to Ophthalmology and Vision Science.

Translational vision science & technology·2025
Same author

Clinical and Scientific Considerations for Whole Eye Transplantation: An Ophthalmologist's Perspective.

Translational vision science & technology·2025
Same author

How Do We Communicate Evidence-Based Medicine?

Translational vision science & technology·2024
Same author

Reply to Comment on Subgroup Analysis From a Phase 1/2 Randomized Clinical Trial of 2.6% EDTA Ophthalmic Solution in Patients With Age-Related Cataract.

American journal of ophthalmology·2024
Same author

Subgroup Analysis from a Phase 1/2 Randomized Clinical Trial of 2.6% EDTA Ophthalmic Solution in Patients with Age-Related Cataract.

American journal of ophthalmology·2024

Related Experiment Video

Updated: Nov 5, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.1K

Corneal Crosslinking in Refractive Corrections.

Viral V Juthani1, Roy S Chuck1

  • 1Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.

Translational Vision Science & Technology
|May 18, 2021
PubMed
Summary
This summary is machine-generated.

Understanding corneal crosslinking biomechanics is crucial for its clinical use. This review covers studies on corneal crosslinking as a primary refractive treatment.

More Related Videos

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.1K
Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

8.0K

Related Experiment Videos

Last Updated: Nov 5, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.1K
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.1K
Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

8.0K

Area of Science:

  • Ophthalmology
  • Biomedical Engineering
  • Corneal Science

Background:

  • Corneal crosslinking (CXL) is a therapeutic procedure.
  • Understanding CXL's biomechanical effects on corneal tissue is essential for clinical success.
  • Various treatment parameters influence CXL outcomes.

Purpose of the Study:

  • To review clinical and laboratory studies on corneal crosslinking (CXL).
  • To evaluate CXL as a primary refractive treatment.
  • To elucidate the biomechanical effects of CXL parameters on corneal tissue.

Main Methods:

  • Review of existing clinical studies.
  • Analysis of laboratory-based research.
  • Evaluation of biomechanical data from CXL studies.

Main Results:

  • Corneal crosslinking demonstrates significant biomechanical changes in corneal tissue.
  • Clinical studies show potential for CXL as a primary refractive procedure.
  • Laboratory findings provide insights into parameter-dependent CXL effects.

Conclusions:

  • A thorough understanding of CXL biomechanics is vital for optimizing its clinical application.
  • Corneal crosslinking shows promise as a primary refractive treatment.
  • Further research is needed to fully establish CXL's role in refractive correction.